Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

NCT00899613 · clinicaltrials.gov ↗

UNKNOWN

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Malignant Mesothelioma
Metastatic Cancer

Interventions

OTHER: laboratory biomarker analysis
PROCEDURE: study of high risk factors

Sponsor

University Hospital, Caen